{"id":"W3192745546","doi":"","title":"胆・膵-膵臓-8.nab-パクリタキセルとFOLFIRINOX:膵癌治療の新たな展開","year":2016,"lang":"en","type":"article","venue":"Canadian parliamentary review","topic":"Military Technology and Strategies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"FOLFIRINOX; Medicine; Internal medicine; Oxaliplatin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009495104,0.0009205715,0.0007015744,0.0038852,0.007635396,0.007481431,0.002431264,0.008485841,0.01171656],"category_scores_gemma":[0.0178189,0.0005529154,0.001116646,0.003769431,0.005033073,0.00286267,0.001873949,0.007366498,0.003099899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04927802,"about_ca_system_score_gemma":0.158441,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.8645204,"about_ca_topic_score_gemma":0.9339622,"domain_scores_codex":[0.9875349,0.001033701,0.0006781265,0.000575849,0.007844795,0.002332643],"domain_scores_gemma":[0.9860874,0.001777746,0.000548786,0.0002782033,0.01037813,0.0009297463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006998474,0.00002911839,0.0006790626,0.001461235,0.00003543027,0.0001502816,0.000933643,0.0001261893,0.0004705654,0.1021686,0.8229062,0.07096981],"study_design_scores_gemma":[0.00001029289,0.00001020853,0.002003859,0.0009128576,0.00003131143,0.00004471932,0.0004904031,0.00002236291,0.0002435535,0.001890366,0.9943164,0.00002363351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.002567752,0.3507518,0.000881944,0.3218259,0.03367632,0.0002011979,0.001382191,0.00009754828,0.2886153],"genre_scores_gemma":[0.1123717,0.2270462,0.003826902,0.2730344,0.006774667,0.0002822779,0.001146875,0.0001574499,0.3753596],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.8645204,"threshold_uncertainty_score":0.3575388,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01155680898119435,"score_gpt":0.202255788196595,"score_spread":0.1906989792154007,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}